Large trials vs meta-analysis of smaller trials - How do their results compare?

被引:297
作者
Cappelleri, JC
Ioannidis, JPA
Schmid, CH
deFerranti, SD
Aubert, M
Chalmers, TC
Lau, J
机构
[1] TUFTS UNIV NEW ENGLAND MED CTR, DIV CLIN CARE RES, BOSTON, MA 02111 USA
[2] TUFTS UNIV NEW ENGLAND MED CTR, DIV GEOG MED & INFECT DIS, BOSTON, MA 02111 USA
[3] TUFTS UNIV NEW ENGLAND MED CTR, BIOSTAT RES CTR, DEPT MED, BOSTON, MA 02111 USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1996年 / 276卷 / 16期
关键词
D O I
10.1001/jama.276.16.1332
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To evaluate the results of large clinical trials vs the pooled resu Data Identification.-Meta-analyses with at least 1 ''large'' study were identified from the Cochrane Pregnancy and Childbirth Database and from MEDLINE (1966-1995), Study Selection.-We used a sample size approach to select 79 meta-analyses with at least 1 large study of 1000 or more patients. We used a statistical power approach to select 61 meta-analyses with at least 1 large study based on statistical power considerations, Data Extraction.-The outcome of interest for each meta-analysis was the primary one stated in the orginal publication or, when not clearly specified, was decided on clinically. Data Synthesis.-By random effects calculations, we found agreement between large and smaller trials in 90% of the meta-analyses selected by the sample size approach and in 82% of the meta-analyses selected by the statistical power approach. Twice as many disagreements appeared when the variability among large studies and among smaller studies was not considered (ie, fixed effects calculations), Of the 15 disagreements between results of large and smaller trials using the random effects model, plausible explanations were identified in 10 meta-analyses: 5 with differences in the control rate of events between large and smaller trials, 4 with specific protocol or study differences, and 1 with potential publication bias, Two other disagreements were not clinically important, and tentative reasons could be identified for 2 of the remaining 3 disagreements, Conclusions.-Results of smaller studies are usually compatible with the results of large studies, but discrepancies do occur even when the diversity among both large studies and smaller studies is considered. Clinically important differences without a potential explanation are extremely uncommon, Future research should further examine sources of heterogeneity between the results of large and smaller trials.
引用
收藏
页码:1332 / 1338
页数:7
相关论文
共 63 条
  • [1] ABE O, 1995, NEW ENGL J MED, V333, P1444
  • [2] ABRAMSON JH, 1994, MAKING SENSE DATA SE, P319
  • [3] COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
    ALTMAN, R
    CARRERAS, L
    DIAZ, R
    FIGUEROA, E
    PAOLASSO, E
    PARODI, JC
    CADE, JF
    DONNAN, G
    EADIE, MJ
    GAVAGHAN, TP
    OSULLIVAN, EF
    PARKIN, D
    RENNY, JTG
    SILAGY, C
    VINAZZER, H
    ZEKERT, F
    ADRIAENSEN, H
    BERTRANDHARDY, JM
    BRAN, M
    DAVID, JL
    DRICOT, J
    LAVENNEPARDONGE, E
    LIMET, R
    LOWENTHAL, A
    MORIAU, M
    SCHAPIRA, S
    SMETS, P
    SYMOENS, J
    VERHAEGHE, R
    VERSTRAETE, M
    ATALLAH, A
    BARNETT, H
    BATISTA, R
    BLAKELY, J
    CAIRNS, JA
    COTE, R
    CROUCH, J
    EVANS, G
    FINDLAY, JM
    GENT, M
    LANGLOIS, Y
    LECLERC, J
    NORRIS, J
    PINEO, GF
    POWERS, PJ
    ROBERTS, R
    SCHWARTZ, L
    SICURELLA, J
    TAYLOR, W
    THEROUX, P
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921): : 81 - 100
  • [4] [Anonymous], 1994, BMJ, V308, P235
  • [5] [Anonymous], 1994, BMJ, V308, P159
  • [6] [Anonymous], 1992, Lancet, V339, P1
  • [7] [Anonymous], 1994, The handbook on research synthesis
  • [9] DRUG-THERAPY - DRUGS AND SURGERY IN THE PREVENTION OF ISCHEMIC STROKE
    BARNETT, HJM
    ELIASZIW, M
    MELDRUM, HE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) : 238 - 248
  • [10] ASPIRIN AND FIBRINOLYSIS IN ACUTE MYOCARDIAL-INFARCTION - META-ANALYTIC EVIDENCE FOR SYNERGY
    BASINSKI, A
    NAYLOR, CD
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1991, 44 (10) : 1085 - 1096